Uploaded March 2024 | Updated September 2026, 2 weeks ago
Did you know that particle accelerators are also used to treat cancer?
That medical imaging has taken great leaps forwards thanks to the crystals and chips developed for particle physics And that CERN is home to a facility that develops isotopes for #medical research? Ever since X-rays were discovered by Wilhelm Röntgen in 1895, physics and medicine have been closely intertwined. Medical imaging and cancer treatments have benefited from developments in particle #physics over the years, and the innovations continue today, including in collaboration with CERN. As part of CERN’s 70th anniversary celebrations, doctors, biologists and physicists will walk you through how the collaboration between fundamental physics and medicine is leading to innovative #treatment methods and diagnostic techniques. One special patient – a researcher, writer and populariser of science – will share with us his experience of being treated for cancer in one of the four European centres for hadron therapy.
Contributors
Director:
Gabrielle Pepin Fontaine De Bonnerive
Did you know that particle accelerators are also used to treat cancer?
That medical imaging has taken great leaps forwards thanks to the crystals and chips developed for particle physics And that CERN is home to a facility that develops isotopes for #medical research? Ever since X-rays were discovered by Wilhelm Röntgen in 1895, physics and medicine have been closely intertwined. Medical imaging and cancer treatments have benefited from developments in particle #physics over the years, and the innovations continue today, including in collaboration with CERN. As part of CERN’s 70th anniversary celebrations, doctors, biologists and physicists will walk you through how the collaboration between fundamental physics and medicine is leading to innovative #treatment methods and diagnostic techniques. One special patient – a researcher, writer and populariser of science – will share with us his experience of being treated for cancer in one of the four European centres for hadron therapy.
Contributors
Director:
Gabrielle Pepin Fontaine De Bonnerive
